Please try another search
Public Joint-Stock Company "Pharmsynthez", a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia, Europe, the United States, and CIS countries. The company offers officinal medicines, including Neovir, Segidrin, Glaumax, Vazostenon, Neostim, Fludarabel, Fenazide, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis. Public Joint-Stock Company "Pharmsynthez" was founded in 1996 and is based in St. Petersburg, Russia.
Name | Age | Since | Title |
---|---|---|---|
Indrek Kasela | 53 | 2007 | Director |
Olga Yur’evna Shpichko | 50 | 2013 | Director |
Nina Vladimirovna Podkolzina | - | - | Member of Audit Commission |
Dmitry Dmitrievich Genkin | 57 | 2005 | Executive Chairman |
Steven Yaroslav Gorelik | 45 | 2007 | Director |
Dmitry Yuryevich Kolosov | 44 | 2013 | Director |
Irina Vladimirovna Ivina | - | - | Member of Audit Commission |
Surkov Kirill Gennadievich | 56 | 2009 | Head of Research & Department and Member of Audit Commission |
Roman Sergeevich Knyazev | 44 | 2013 | Director |
Artem Vladimirovich Orlov | - | 2013 | Director |
Aleksandr Aleksandrovich Zaporozhtsev | - | - | Member of Audit Commission |
Yevgeniy Lugovets | - | 2018 | Member of Audit Commission |
Valentin Zubov | - | 2018 | Member of Audit Commission |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review